0000899243-23-011187.txt : 20230412 0000899243-23-011187.hdr.sgml : 20230412 20230412161509 ACCESSION NUMBER: 0000899243-23-011187 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230410 FILED AS OF DATE: 20230412 DATE AS OF CHANGE: 20230412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Armanino Andrew J. CENTRAL INDEX KEY: 0001807550 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39864 FILM NUMBER: 23815864 MAIL ADDRESS: STREET 1: C/O CALIFORNIA BANCORP STREET 2: 1300 CLAY STREET, FIFTH FLOOR CITY: OAKLAND STATE: CA ZIP: 94612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Better Therapeutics, Inc. CENTRAL INDEX KEY: 0001832415 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 548 MARKET ST. #49404 CITY: SAN FRANCISCO STATE: CA ZIP: 94101 BUSINESS PHONE: 415-887-2311 MAIL ADDRESS: STREET 1: 548 MARKET ST. #49404 CITY: SAN FRANCISCO STATE: CA ZIP: 94101 FORMER COMPANY: FORMER CONFORMED NAME: Mountain Crest Acquisition Corp II DATE OF NAME CHANGE: 20201116 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-10 0 0001832415 Better Therapeutics, Inc. BTTX 0001807550 Armanino Andrew J. C/O BETTER THERAPEUTICS, INC. 548 MARKET STREET, #49404 SAN FRANCISCO CA 94104 1 0 0 0 0 Common Stock 2023-04-10 4 P 0 303030 0.825 A 454358 I By Armanino Trust Common Stock 13334 D On April 6, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.825 per share. As one of the PIPE Investors, the Reporting Person acquired 303,030 shares of Issuer common stock on April 10, 2023 for $0.825 per share. The Reporting Person no longer has a reportable beneficial interest in 15,000 shares of Issuer common stock owned by his son and included in the Reporting Person's prior ownership report on Form 4. These shares are owned directly by the Andrew J. Armanino III and Denise M. Armanino Family Trust (the "Armanino Trust"), and indirectly by the Reporting Person and his spouse, Denise M. Armanino, as trustees of the Armanino Trust. /s/ Mark Heinen, Attorney-in-Fact 2023-04-12